These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34365941)

  • 1. Targeted Protein Degradation and Regulation with Molecular Glue: Past and Recent Discoveries.
    Fang Y; He Q; Cao J
    Curr Med Chem; 2022; 29(14):2490-2503. PubMed ID: 34365941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-Guided Protein Degradation by Immunomodulatory Imide Drug-Based Molecular Glues and Proteolysis Targeting Chimeras.
    Chen H; Liu J; Kaniskan HÜ; Wei W; Jin J
    J Med Chem; 2021 Aug; 64(16):12273-12285. PubMed ID: 34378936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic.
    Sasso JM; Tenchov R; Wang D; Johnson LS; Wang X; Zhou QA
    Biochemistry; 2023 Feb; 62(3):601-623. PubMed ID: 35856839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer.
    Barghout SH
    Anticancer Agents Med Chem; 2021; 21(2):214-230. PubMed ID: 32275492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery.
    Dong G; Ding Y; He S; Sheng C
    J Med Chem; 2021 Aug; 64(15):10606-10620. PubMed ID: 34319094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders.
    Hughes SJ; Ciulli A
    Essays Biochem; 2017 Nov; 61(5):505-516. PubMed ID: 29118097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction.
    Rui H; Ashton KS; Min J; Wang C; Potts PR
    RSC Chem Biol; 2023 Mar; 4(3):192-215. PubMed ID: 36908699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing protein-protein interactions with molecular glues.
    Che Y; Gilbert AM; Shanmugasundaram V; Noe MC
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2585-2592. PubMed ID: 29980357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging mechanisms of targeted protein degradation by molecular glues.
    Frere GA; de Araujo ED; Gunning PT
    Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.
    Rana S; Mallareddy JR; Singh S; Boghean L; Natarajan A
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new avenue for molecular glues: Rapid discovery of a NFKB1 degrader.
    Fan AT; Boyle BT; Ferguson FM
    Cell Chem Biol; 2023 Apr; 30(4):340-342. PubMed ID: 37084716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.
    Luh LM; Scheib U; Juenemann K; Wortmann L; Brands M; Cromm PM
    Angew Chem Int Ed Engl; 2020 Sep; 59(36):15448-15466. PubMed ID: 32428344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment.
    Wu H; Yao H; He C; Jia Y; Zhu Z; Xu S; Li D; Xu J
    Acta Pharm Sin B; 2022 Sep; 12(9):3548-3566. PubMed ID: 36176907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-Targeted Degradation Agents Based on Natural Products.
    Li Y; Jia Y; Wang X; Shang H; Tian Y
    Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted protein degradation: mechanisms, strategies and application.
    Zhao L; Zhao J; Zhong K; Tong A; Jia D
    Signal Transduct Target Ther; 2022 Apr; 7(1):113. PubMed ID: 35379777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of molecular glues of the SLP76/14-3-3 protein-protein interaction.
    Soini L; Redhead M; Westwood M; Leysen S; Davis J; Ottmann C
    RSC Med Chem; 2021 Sep; 12(9):1555-1564. PubMed ID: 34667951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of thalidomide and its derivatives.
    Ito T; Handa H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(6):189-203. PubMed ID: 32522938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors.
    Dai M; Radhakrishnan S; Li R; Tan R; Yan K; Fan G; Liu M
    Technol Cancer Res Treat; 2022; 21():15330338221095950. PubMed ID: 35466792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.
    Jan M; Sperling AS; Ebert BL
    Nat Rev Clin Oncol; 2021 Jul; 18(7):401-417. PubMed ID: 33654306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
    Collins I; Wang H; Caldwell JJ; Chopra R
    Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.